Copyright
©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Sep 7, 2014; 20(33): 11574-11585
Published online Sep 7, 2014. doi: 10.3748/wjg.v20.i33.11574
Published online Sep 7, 2014. doi: 10.3748/wjg.v20.i33.11574
Alteration | Type of alteration | Clinical application | Ref. |
HER-2 amplification | Genetic | Prognostic and therapeutic | [34-40] |
MYC amplification | Genetic | Progression and metastasis | [52] |
TP53 Arg72Pro | Genetic | Risk predictor, prognostic | [63-67,69-72] |
CDH1 -160 C>A | Genetic | Risk predictor | [76-78] |
CDH1 hypermethylation | Epigenetic | Prognostic, metastasis | [167,170,171] |
p16 hypermethylation | Epigenetic | Diagnostic, prognostic and therapeutic | [156-160] |
- Citation: Pinheiro DDR, Ferreira WAS, Barros MBL, Araújo MD, Rodrigues-Antunes S, Borges BDN. Perspectives on new biomarkers in gastric cancer: Diagnostic and prognostic applications. World J Gastroenterol 2014; 20(33): 11574-11585
- URL: https://www.wjgnet.com/1007-9327/full/v20/i33/11574.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i33.11574